Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd announces FY 2013 net profit outlook


Tuesday, 14 Jan 2014 07:00pm EST 

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd:Sees net profit for the fiscal year (FY) 2013 to be approximately 1 million yuan to 5 million yuan.Says the net profit of the same period in FY 2012 was -88,842,449.68 yuan.Says the reason for positive outlook is due to the cost reduction, the increased sales and the record of investment profit. 

Company Quote